Cortisol assays and diagnostic laboratory procedures in human biological fluids

Clinical Biochemistry

Volumn 42, Issue 12, 2009, Pages 1205-1217

  Gatti, Rosalba ^a   Antonelli, Giorgia ^a   Prearo, Maddalena ^a   Spinella, Paolo ^a   Cappellin, Enrico ^a,b   De Palo, Elio F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Medical Sciences University of Padova ^*  (Italy)

Author keywords

Analytical performance; Diagnostic performance; Interference; Reference range; Steroid

Indexed keywords

HYDROCORTISONE;

ADDISON DISEASE; ALCOHOLISM; ANALYTIC METHOD; BODY FLUID; CHROMATOGRAPHY; CONGENITAL ADRENAL HYPERPLASIA; CUSHING SYNDROME; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; ENDOCRINE DISEASE; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; MENTAL DISEASE; MORBID OBESITY; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ADDISON DISEASE; BIOLOGICAL ASSAY; BODY FLUIDS; CIRCADIAN RHYTHM; CUSHING SYNDROME; HUMANS; HYDROCORTISONE; LABORATORY TECHNIQUES AND PROCEDURES; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SALIVA; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SPECIMEN HANDLING; STRESS, PHYSIOLOGICAL;

EID: 67650762781     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.04.011     Document Type: Review

References (120)

1. Findling J.W., and Raff H. Cushing's syndrome: important issues in diagnosis and management. J. Clin. Endocrinol. Metab. 91 (2006) 3746-3753
2. Nieman L.K. Dynamic evaluation of adrenal hypofunction. J. Endocrinol. Invest. 26 (2003) 74-82
3. Remer T., Maser-Gluth C., and Wudy S.A. Glucocorticoid measurements in health and disease metabolic implications and the potential of 24-h urine analyses. Mini. Rev. Med. Chem. 8 (2008) 153-170
4. Murphy B.E.P. Urinary free cortisol determinations: what they measure. Endocrinologist 12 (2002) 143-150
5. Murphy B.E.P. Lack of specificity of urinary free cortisol determinations: why does it continue?. J. Clin. Endocrinol. Metab. 84 (1999) 2258-2259
6. Sapin R., Schlienger J.L., Gasser F., Pradignac A., and Grucker D. Improved specificity of a new direct assay for urinary cortisol: application in corticoid treated patients. Clin. Chem. Lab. Med. 36 (1998) 855-858
7. Nahoul K., Patricot M.C., Moatti J.P., and Revol A. Determination of urinary cortisol with three commercial immunoassays. J. Steroid. Biochem. Mol. Biol. 43 (1992) 573-580
8. Poll E.M., Kreitschmann-Andermahr I., Langejuergen Y., Stanzel S., Gilsbach J.M., Gressner A., et al. Saliva collection method affects predictability of serum cortisol. Clin. Chim. Acta 382 (2007) 15-19
9. Gröschl M., and Rauh M. Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis. Steroids 7 (2006) 1097-1100
10. Granger D.A., Kivlighan K.T., Fortunato C., Harmon A.G., Hibel L.C., Schwartz E.B., et al. Integration of salivary biomarkers into developmental and behaviourally-oriented research: problems and solutions for collecting specimens. Physiol. Behav. 92 (2007) 583-590
11. Miller D.B., and O'Callaghan J.P. Neuroendocrine aspects of the response to stress. Metabolism 51 (2002) 5-10
12. Saiah E. The role of 11beta-hydroxysteroid dehydrogenase in metabolic disease and therapeutic potential of 11beta-hsd1 inhibitors. Curr. Med. Chem. 15 7 (2008) 642-649
13. Frey F.J., Odermatt A., and Frey B.M. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr. Opin. Nephrol. Hypertens. 13 (2004) 451-458
14. Bauer M.E. Chronic stress and immunosenescence: a review. Neuroimmunomodulation 15 (2008) 241-250
15. Atanasov A.G., and Odermatt A. Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity?. Endocr. Metab. Immune. Disord. Drug Targets 7 (2007) 125-140
16. Torpy D.J., and Ho J.T. Corticosteroid-binding globulin gene polymorphisms: clinical implications and links to idiopathic chronic fatigue disorders. Clin. Endocrinol. (Oxf) 67 (2007) 161-167
17. Breuner C.W., and Orchinik M. Plasma binding proteins as mediators of corticosteroid action in vertebrates. J. Endocrinol. 175 (2002) 99-112
18. Levine A., Zagoory-Sharon O., Feldman R., Lewis J.G., and Weller A. Measuring cortisol in human psychobiological studies. Physiol. Behav. 90 (2007) 43-53
19. Wade S.E., and Haegele A.D. Time-integrated measurement of corticosteroids in saliva by oral diffusion sink technology. Clin. Chem. 37 (1991) 1166-1172
20. Engeland W.C., and Arnhold M.M. Neural circuitry in the regulation of adrenal corticosterone rhythmicity. Endocrine 28 (2005) 325-22
21. Young E.A., Abelson J., and Lightman S.L. Cortisol pulsatility and its role in stress regulation and health. Front. Neuroendocrinol. 25 (2004) 69-76
22. Van Cauter E., Leproult R., and Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81 (1996) 2468-2473
23. Morineau G., Gosling J., Patricot M.C., et al. Convenient chromatographic prepurification step before measurement of urinary cortisol by radioimmunoassay. Clin. Chem. 43 (1997) 786-793
24. Draper N., and Stewart P.M. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J. Endocrinol. 186 2 (2005) 251-271
25. Tomlinson J.W., Walker E.A., Bujalska I.J., et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 25 (2004) 831-866
26. Quinkler M., and Stewart P.M. Hypertension and the cortisol-cortisone shuttle. J. Clin. Endocrinol. Metab. 88 (2003) 2384-2392
27. Kataoka S., Kudo A., Hirano H., et al. 11beta-hydroxysteroid dehydrogenase type 2 is expressed in the human kidney glomerulus. J. Clin. Endocrinol. Metab. 87 (2002) 877-882
28. Odermatt A., and Atanasov A.G. Mineralocorticoid receptors: emerging complexity and functional diversity. Steroids 74 (2009) 163-171
29. Kuhnle U., Lewicka S., and Fuller P.J. Endocrine disorders of sodium regulation. Horm. Res. 61 (2004) 68-83
30. Lavery G.G., Ronconi V., Draper N., Rabbitt E.H., Lyons V., Chapman K.E., et al. Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene. Hypertension 42 (2003) 123-129
31. Derijk R.H., and de Kloet E.R. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur. J. Pharmacol. 583 2-3 (2008) 303-311
32. Booth R.E., Johnson J.P., and Stockand J.D. Aldosterone. Adv. Physiol. Educ. 26 (2002) 8-20
33. Hammer F., and Stewart P.M. Cortisol metabolism in hypertension. Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006) 337-353
34. Suri D., Moran J., Hibbard J.U., Kasza K., and Weiss R.E. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test. J. Clin. Endocrinol. Metab. 91 (2006) 3866-3872
35. Timon R., Olcina G., Maynar M., Muñoz D., Caballero M.J., and Maynar J.I. Evaluation of urinary steroid profile in highly trained cyclists. J. Sports Med. Phys. Fitness 48 (2008) 530-534
36. Hill E.E., Zack E., Battaglini C., Viru M., Viru A., and Hackney A.C. Exercise and circulating cortisol levels: the intensity threshold effect. J. Endocrinol. Invest. 31 (2008) 587-591
37. Duclos M., Guinot M., and Le Bouc Y. Cortisol and GH: odd and controversial ideas. Appl. Physiol. Nutr. Metab. 32 (2007) 895-903
38. Gatti R, Cappellin E, Zecchin B, et al. Urinary high performance reverse phase chromatography cortisol and cortisone analyses before and at the end of a race in elite cyclists. J Chromatogr. B Analyt Technol Biomed Life Sci 2005;824(1-2):51-6. Corrected and republished in: J Chromatogr B Analyt Technol Biomed Life Sci 2005;829: 154-9.
39. Tremblay M.S., Copeland J.L., and Van Helder W. Influence of exercise duration on post-exercise steroid hormone responses in trained males. Eur. J. Appl. Physiol. 94 (2005) 505-513
40. Løvås K., Thorsen T.E., and Husebye E.S. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. J. Endocrinol. Invest. 29 (2006) 727-731
41. Demirci C., and Witchel S.F. Congenital adrenal hyperplasia. Dermatol. Ther. 21 (2008) 340-353
42. Parker A.J., Wessely S., and Cleare A.J. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol. Med. 31 (2001) 1331-1345
43. Meewisse M.L., Reitsma J.B., de Vries G.J., Gersons B.P., and Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br. J. Psychiatry 191 (2007) 387-392
44. Fries E., Hesse J., Hellhammer J., and Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 30 (2005) 1010-1016
45. Reimondo G., Pia A., Bovio S., et al. Laboratory differentiation of Cushing's syndrome. Clin. Chim. Acta 388 (2008) 5-14
46. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol. Metab. Clin. North Am. 34 (2005) 271-292
47. Matchock R.L., Dorn L.D., and Susman E.J. Diurnal and seasonal cortisol, testosterone, and DHEA rhythms in boys and girls during puberty. Chronobiol. Int. 24 (2007) 969-990
48. Hansen A.M., Garde A.H., and Persson R. Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review. Scand. J. Clin. Lab. Invest. 68 (2008) 448-458
49. Young E.A., Abelson J., and Lightman S.L. Cortisol pulsatility and its role in stress regulation and health. Front Neuroendocrinol. 25 (2004) 69-76
50. Jerjes W.K., Cleare A.J., Peters T.J., and Taylor N.F. Circadian rhythm of urinary steroid metabolites. Ann. Clin. Biochem. 43 (2006) 287-294
51. Dorn L.D., Lucke J.F., Loucks T.L., and Berga S.L. Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann. Clin. Biochem. 44 (2007) 281-284
52. Lasikiewicz N., Hendrickx H., Talbot D., and Dye L. Exploration of basal diurnal salivary cortisol profiles in middle-aged adults: associations with sleep quality and metabolic parameters. Psychoneuroendocrinology 33 (2008) 143-151
53. Viardot A., Huber P., Puder J.J., Zulewski H., Keller U., and Müller B. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90 (2005) 5730-5736
54. Gozansky W.S., Lynn J.S., Laudenslager M.L., and Kohrt W.M. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin. Endocrinol. (Oxf) 63 (2005) 336-341
55. Arafah B.M., Nishiyama F.J., Tlaygeh H., and Hejal R. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J. Clin. Endocrinol. Metab. 92 (2007) 2965-2971
56. Gröschl M. Current status of salivary hormone analysis. Clin. Chem. 54 (2008) 1759-1769
57. Gallagher P., Leitch M.M., Massey A.E., McAllister-Williams R.H., and Young A.H. Assessing cortisol and dehydroepiandrosterone (DHEA) in saliva: effects of collection method. J. Psychopharmacol. 20 (2006) 643-649
58. Dockray S., Bhattacharyya M.R., Molloy G.J., and Steptoe A. The cortisol awakening response in relation to objective and subjective measures of waking in the morning. Psychoneuroendocrinology 33 (2008) 77-82
59. Thorn L., Hucklebridge F., Evans P., and Clow A. The cortisol awakening response, seasonality, stress and arousal: a study of trait and state influences. Psychoneuroendocrinology 34 (2009) 299-306
60. Hansen A.M., Garde A.H., and Persson R. Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review. Scand. J. Clin. Lab. Invest. 68 (2008) 448-458
61. Philomin V., Vessières A., and Jaouen G. New applications of carbonylmetalloimmunoassay (CMIA): a non-radioisotopic approach to cortisol assay. J. Immunol. Methods 16 171 (1994) 201-210
62. Janzen N., Sander S., Terhardt M., Peter M., and Sander J. Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 861 (2008) 117-122
63. Kushnir M.M., Neilson R., Roberts W.L., and Rockwood A.L. Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry. Clin. Biochem. 37 (2004) 357-362
64. Vogeser M., Briegel J., and Jacob K. Determination of serum cortisol by isotope-dilution liquid-chromatography electrospray ionization tandem mass spectrometry with on-line extraction. Clin. Chem. Lab. Med. 39 (2001) 944-947
65. Canalis E., Caldarella A.M., and Reardon G.E. Serum cortisol and 11 deoxycortisol by liquid chromatography: clinical studies and comparison with radioimmunoassay. Clin. Chem. 25 (1979) 1700-1703
66. Roberts R.F., and Roberts W.L. Performance characteristics of five automated serum cortisol immunoassays. Clin. Biochem. 37 (2004) 489-493
67. Nye E.J., Grice J.E., Hockings G.I., et al. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests. J. Clin. Endocrinol. Metab. 84 (1999) 3648-3655
68. Caldarella A.M., Reardon G.E., and Canalis E. Analysis for cortisol in serum by liquid chromatography. Clin. Chem. 28 (1982) 538-543
69. Restituto P., Galofré J.C., Gil M.J., et al. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin. Biochem. 41 (2008) 688-692
70. Riepe F.G., and Sippell W.G. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Rev. Endocr. Metab. Disord. 8 (2007) 349-363
71. Barsano C.P., and Bauman G. Simple algebraic and graphic methods for the apportionment of hormone (and receptor) into bound and free fractions in binding equilibria; or how to calculate bound and free hormone?. Endocrinology 124 (1989) 1101-1107
72. Ho J.T., Al-Musalhi H., Chapman M.J., et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J. Clin. Endocrinol. Metab. 91 (2006) 105-114
73. Coolens J.L., Van Baelen H., and Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J. Steroid. Biochem. 26 (1987) 197-202
74. Dorin R.I., Pai H.K., Ho J.T., Lewis J.G., Torpy D.J., Urban F.K., et al. Validation of a simple method of estimating plasma free cortisol: role of cortisol binding to albumin. Clin. Biochem. 42 (2009) 64-71
75. Vogeser M., and Briegel J. Effect of temperature on protein binding of cortisol. Clin. Biochem. 40 (2007) 724-727
76. Vogeser M., Mohnle P., and Briegel J. Free serum cortisol: quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system. Clin. Chem. Lab. Med. 45 (2007) 521-525
77. Arafah B.M. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J. Clin. Endocrinol. Metab. 91 (2006) 3725-3745
78. Pemberton P.A., Stein P.E., Pepys M.B., Potter J.M., and Carrell R.W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336 (1988) 257-258
79. Rosner W. Plasma steroid-binding globulins. Endocrinol. Metab. Clin. North Am. 20 (1991) 697-720
80. Horie H., Kidowaki T., Koyama Y., et al. Specificity assessment of immunoassay kits for determination of urinary free cortisol concentrations. Clin. Chim. Acta 378 (2007) 66-70
81. Ching S.Y., Lim E.M., Beilby J., et al. Urine free cortisol analysis by automated immunoassay and high-performance liquid chromatography for the investigation of Cushing's syndrome. Ann. Clin. Biochem. 43 (2006) 402-407
82. Kennedy D.M., Selby C., and Lawson N. Measurement of urinary free cortisol using the ACS:180 serum cortisol chemiluminescent immunoassay. Ann. Clin. Biochem. 7 (2000) 520-528
83. McCann S., Gillingwater S., and Keevil B.G. Measurement of urinary free cortisol using liquid chromatography-tandem mass spectrometry: comparison with the urine adapted ACS:180 serum cortisol chemiluminescent immunoassay and development of a new reference range. Ann. Clin. Biochem. 42 (2005) 112-118
84. Turpeinen U., Markkanen H., Välimäki M., and Stenman U. Determination of urinary free cortisol by HPLC. Clin. Chem. 43 (1997) 1386-1391
85. Lin C.L., Wu T.J., Machacek D.A., Jiang N.A., and Kao P.C. Urinary free cortisol and cortisone determined by high performance liquid Chromatography in the diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metab. 82 (1997) 151-155
86. Kobayashi N., Sun P., Fujimaki Y., et al. Generation of a novel monoclonal antibody against cortisol-[C-4]-bovine serum albumin conjugate: application to enzyme-linked immunosorbent assay for urinary and serum cortisol. Anal. Sci. 18 (2002) 1309-1314
87. Shibasaki H., Nakayama H., Furuta T., et al. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 870 (2008) 164-169
88. Wood L., Ducroq D.H., Fraser H.L., et al. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann. Clin. Biochem. 45 (2008) 380-388
89. Wear J.E., Owen L.J., Duxbury K., and Keevil B.G. A simplified method for the measurement of urinary free cortisol using LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 858 (2007) 27-31
90. Rockwood A.L., Nelson G.J., Yue B., and Urry F.M. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin. Biochem. 38 (2005) 319-327
91. Kushnir M.M., Kushnir M.M., Rockwood A.L., Nelson G.J., Terry A.H., and Meikle A.W. Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol. Clin. Chem. 49 (2003) 965-967
92. Taylor R.L., Machacek D., and Singh R.J. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin. Chem. 48 (2002) 1511-1519
93. Kikuchi E., Yanaihara H., Nakashima J., et al. Urinary steroid profile in adrenocortical tumors. Biomed. Pharmacother. 54 (2000) 194s-197s
94. Pujos E., Flament-Waton M.M., Paisse O., and Grenier-Loustalot M.F. Comparison of the analysis of corticosteroids using different techniques. Anal. Bioanal. Chem. 381 (2005) 244-254
95. Vining R.F., McGlingey R.A., and Symons R.G. Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clin. Chem. 29 (1983) 1752-1756
96. Chiappin S., Antonelli G., Gatti R., and De Palo E.F. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin. Chim. Acta 383 (2007) 30-40
97. Raff H., Raff J.L., and Findling J.W. Late-night salivary cortisol as a screening test for Cushing's syndrome. J. Clin. Endocrinol. Metab. 83 (1998) 2681-2686
98. Jonsson Bo A.G., Malmberg B., Amilon A., Garde A.H., and Ørbæk P. Determination of cortisol in human saliva using liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B. 784 (2003) 63-68
99. Raff H., Homar P.J., and Skoner D.P. New enzyme immunoassay for salivary cortisol. Clin. Chem. 49 (2003) 203-204
100. Raff H., Homar P.J., and Burns E.A. Comparison of two methods for measuring salivary cortisol. Clin. Chem. 48 (2002) 207-208
101. Chiu S.K., Collier C.P., Clark A.F., and Wynn-Edwards K.E. Salivary cortisol on ROCHE Elecsys immunoassay system: pilot biological variation studies. Clin. Biochem. 36 (2003) 211-214
102. Pivonello R., De Martino M.C., De Leo M., Lombardi G., and Colao A. Cushing's syndrome. Endocrinol. Metab. Clin. North Am. 37 (2008) 135-149
103. Newell-Price J., and Grossman A.B. Differential diagnosis of Cushing's syndrome. Arq. Bras. Endocrinol. Metabol. 51 (2007) 1199-1206
104. Gatti R., Antonelli G., Zecchin B., Spinella P., Mantero F., and De Palo E.F. Urine cortisol and cortisone and water intake in athletes. J. Sports Med. Phys. Fitness 48 (2008) 404-408
105. Shi L., Maser-Gluth C., and Remer T. Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children. Steroids 73 (2008) 1446-1451
106. Fenske M. Thin-layer chromatographic competitive protein-binding assay for cortisol and cortisone, and its application to urine samples from healthy men undergoing water diuresis. Chromatographia 63 (2006) 383-388
107. Ayala A.R., Ilias I., and Nieman L.K. The spectrum effect in the evaluation of Cushing syndrome. Curr. Opin. Endocrinol. Diab. 10 (2003) 272-276
108. Yaneva M., Mosnier-Pudar H., Dugue M.A., Grabar S., Fulla Y., and Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J. Clin. Endocrinol. Metab. 89 (2004) 3345-3351
109. Papanicolaou D.A., Mullen N., Kyrou I., and Nieman L.K. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metab. 87 (2002) 4515-4521
110. Papanicolaou D.A., Yanovski J.A., Cutler Jr. G.B., Chrousos G.P., and Nieman L.K. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J. Clin. Endocrinol. Metab. 83 (1998) 1163-1167
111. Putignano P., Toja P., Dubini A., Giraldi F.P., Corsello S.M., and Cavagnini F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J. Clin. Endocrinol. Metab. 88 (2003) 4153-4157
112. Castro M., Elias P.C., Martinelli Jr. C.E., Antonini S.R., Santiago L., and Moreira A.C. Salivary cortisol as a tool for physiological studies and diagnostic strategies. Braz. J. Med. Biol. Res. 33 (2000) 1171-1175
113. Arnaldi G., Angeli A., Atkinson A.B., et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88 (2003) 5593-5602
114. Reimondo G., Allasino B., Bovio S., Paccotti P., Angeli A., and Terzolo M. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome. Eur. J. Endocrinol. 153 (2005) 803-809
115. Newell-Price J., Trainer P., Perry L., Wass J., Grossman A., and Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin. Endocrinol. (Oxf). 43 (1995) 545-550
116. Castro M., Elias P.C., Quidute A.R., Halah F.P., and Moreira A.C. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J. Clin. Endocrinol. Metab. 84 (1999) 878-882
117. Baid S.K., Sinaii N., Wade M., Rubino D., and Nieman L.K. Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J. Clin. Endocrinol. Metab. 92 (2007) 3102-3107
118. Arregger A.L., Cardoso E.M., Tumilasci O., and Contreras L.N. Diagnostic value of salivary cortisol in end stage renal disease. Steroids 73 (2008) 77-82
119. Vogeser M., Durner J., Seliger E., and Auernhammer C. Measurement of late-night salivary cortisol with an automated immunoassay system. Clin. Chem. Lab. Med. 44 (2006) 1441-1445
120. Doi M., Sekizawa N., Tani Y., et al. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome. Japan Endocr. J. 55 (2008) 121-126